Publication | Closed Access
Extended follow-up of outcome measures in multiple myeloma patients treated on a phase I study with bortezomib and pegylated liposomal doxorubicin
46
Citations
13
References
2006
Year
Hematological MalignancyMedicineHematologyMyeloid NeoplasiaPathologyLiposomal DoxorubicinMultiple Myeloma PatientsOncologyRadiation OncologyOutcome MeasuresHealth Sciences
| Year | Citations | |
|---|---|---|
Page 1
Page 1